Literature DB >> 30408781

Derived Subendocardial Viability Ratio and Cardiovascular Events in Patients with Chronic Kidney Disease.

Robert Ekart1,2, Sebastjan Bevc3,4, Nina Hojs3,4, Radovan Hojs3,4.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a well-known mortality risk factor. The subendocardial viability ratio (SEVR) is one of the pulse wave analysis parameters that constitutes a non-invasive measure of coronary perfusion. We aimed to assess the prognostic value of the SEVR for cardiovascular outcome in non-dialysis CKD patients.
METHODS: A total of 98 CKD patients (mean age 60 years) were prospectively followed up from the date of the SEVR measurement until their death or the start of dialysis/transplantation, maximally up to 7.1 years (mean 5 years). According to the manufacturer's instructions regarding normal SEVR values, the patients were divided into a low SEVR group (SEVR ≤130%, n = 26) and a normal SEVR group (SEVR > 130%, n = 72).
RESULTS: During the follow-up period, 13 patients (13.3%) suffered fatal and 23 patients (23.5%) suffered combined (non-fatal and fatal) cardiovascular events. In the patients who died of cardiovascular causes, the SEVR values were statistically significantly lower (130 vs. 154%; p = 0.017) than in those who survived. A Kaplan-Meier survival analysis showed that the cardiovascular survival rate in the low SEVR group of patients was statistically significantly lower (log-rank test: p < 0.001). Using an unadjusted Cox regression analysis, the patients in the low SEVR group had a 5.6-fold higher risk (95% CI: 1.8-17.3; p = 0.002) of fatal cardiovascular events and a 2.7-fold higher risk (95% CI: 1.1-6.3; p = 0.024) of combined fatal and non-fatal cardiovascular events. In the adjusted Cox regression model, the patients in the low SEVR group had a 16-fold higher risk (95% CI: 1.2-9.7; p = 0.004) of fatal cardiovascular events and a 7-fold higher risk (95% CI: 1-9.7; p = 0.009) of combined fatal and non-fatal cardiovascular events.
CONCLUSIONS: An SEVR < 130% predicts fatal and non-fatal cardiovascular events in non-dialysis CKD patients.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Applanation tonometry; Cardiovascular mortality; Chronic kidney disease; Subendocardial viability ratio

Mesh:

Year:  2018        PMID: 30408781     DOI: 10.1159/000493512

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  4 in total

1.  Arterial Stiffness, Subendocardial Impairment, and 30-Day Readmission in Heart Failure Older Patients.

Authors:  Francesco Fantin; Anna Giani; Arianna Franconi; Elena Zoico; Silvia Urbani; Andrea P Rossi; Gloria Mazzali; Mauro Zamboni
Journal:  Front Cardiovasc Med       Date:  2022-06-17

2.  Six-Week Exercise Training With Dietary Restriction Improves Central Hemodynamics Associated With Altered Gut Microbiota in Adolescents With Obesity.

Authors:  Junhao Huang; Jingwen Liao; Yang Fang; Hailin Deng; Honggang Yin; Bing Shen; Min Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-07       Impact factor: 5.555

3.  Impaired subendocardial perfusion in patients with metabolic syndrome.

Authors:  Francesco Fantin; Anna Giani; Ludovico Gasparini; Andrea P Rossi; Elena Zoico; Gloria Mazzali; Mauro Zamboni
Journal:  Diab Vasc Dis Res       Date:  2021 Nov-Dec       Impact factor: 3.291

Review 4.  Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk.

Authors:  Nejc Piko; Sebastjan Bevc; Robert Ekart; Tadej Petreski; Nina Vodošek Hojs; Radovan Hojs
Journal:  World J Diabetes       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.